Fanconi anemia type C–deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8
- 30 September 2004
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 32 (9) , 815-821
- https://doi.org/10.1016/j.exphem.2004.06.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosisLeukemia, 2003
- A novel ubiquitin ligase is deficient in Fanconi anemiaNature Genetics, 2003
- The Fanconi anaemia/BRCA pathwayNature Reviews Cancer, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- The Fanconi anemia group C gene product: Signaling functions in hematopoietic cellsExperimental Hematology, 2001
- Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling ComplexJournal of Biological Chemistry, 2001
- The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis SystemsExperimental Cell Research, 2000
- MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.Journal of Clinical Investigation, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995